Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients

Lasse H Jakobsen*, Fredrik Ellin, Knut B Smeland, Tove Wästerlid, Jacob H Christensen, Judit M Jørgensen, Pär L Josefsson, Andreas K Øvlisen, Harald Holte, Yngvild N Blaker, Jacob H Grauslund, Jon Bjørn, Daniel Molin, Ingemar Lagerlöf, Karin E Smedby, Katherine Colvin, Gita Thanarajasingam, Matthew J Maurer, Thomas M Habermann, Kevin W SongKatie Y Zhu, Alina S Gerrie, Chan Y Cheah, Tarec C El-Galaly

*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

11 Citationer (Scopus)
26 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients'. Sammen danner de et unikt fingeraftryk.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science